324 related articles for article (PubMed ID: 2687626)
1. Optimization of metabolic activation for four mutagens in a bacterial, fungal and two mammalian cell mutagenesis assays.
Rees RW; Brice AJ; Carlton JB; Gilbert PJ; Mitchell ID
Mutagenesis; 1989 Sep; 4(5):335-42. PubMed ID: 2687626
[TBL] [Abstract][Full Text] [Related]
2. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
Gatehouse DG; Paes DJ
Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide: lack of mutagenic activity across phyla and genetic endpoints.
Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J
Mutat Res; 1997 Dec; 396(1-2):45-64. PubMed ID: 9434859
[TBL] [Abstract][Full Text] [Related]
4. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
Rashid KA; Babish JG; Johnson BE; Mumma RO
Toxicology; 1985 Aug; 36(2-3):139-46. PubMed ID: 3931301
[TBL] [Abstract][Full Text] [Related]
5. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
6. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
Amacher DE; Turner GN
Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853
[TBL] [Abstract][Full Text] [Related]
7. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
8. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
Gatehouse D; Wedd DJ
Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
[TBL] [Abstract][Full Text] [Related]
10. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
11. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
Traynor CA; Shane BS; Hajos AK; Winston GW
Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
[TBL] [Abstract][Full Text] [Related]
12. Metabolic activation of 3-nitroperylene in the Salmonella/S9 assay.
Anderson JG; McCalla DR; Bryant DW; McCarry BE; Bromke AM
Mutagenesis; 1987 Jul; 2(4):279-85. PubMed ID: 3325759
[TBL] [Abstract][Full Text] [Related]
13. Activation and detoxification of dinitropyrenes by cytosol and microsomes from Aroclor-pretreated rats in the Ames and umu assays.
Shane BS; Winston GW
Environ Mol Mutagen; 1997; 30(3):303-11. PubMed ID: 9366909
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation of organic extracts from diesel, coke oven, roofing tar, and cigarette smoke emissions in the Ames assay.
Williams K; Lewtas J
Environ Mutagen; 1985; 7(4):489-500. PubMed ID: 2414095
[TBL] [Abstract][Full Text] [Related]
15. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
Kevekordes S; Porzig J; Gebel T; Dunkelberg H
Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the relationship of metabolic activation system concentrations and chemical dose concentrations for the Salmonella spiral and plate assays.
Claxton LD; Houk VS; Allison JC; Creason J
Mutat Res; 1991 Oct; 253(2):127-36. PubMed ID: 1922139
[TBL] [Abstract][Full Text] [Related]
17. Activation and detoxication of promutagens by toadfish (Opsanus tau) hepatic postmitochondrial fractions in the Salmonella assay.
Milling DM; Maddock MB
Mutat Res; 1986 Apr; 164(2):81-9. PubMed ID: 3515163
[TBL] [Abstract][Full Text] [Related]
18. Mutagenic evaluation of the hair-dye component 2,4-diaminophenoxyethanol in Salmonella typhimurium/microsome plate test and Saccharomyces cerevisiae strains D4 and XV185-14C.
Shahin MM; Bugaut A; Kalopissis G
Mutat Res; 1982 Dec; 102(4):319-29. PubMed ID: 6757736
[TBL] [Abstract][Full Text] [Related]
19. Microbial mutation studies with tetrachlorvinphos (Gardona)).
Brooks TM; Dean BJ; Hutson DH; Potter D
Mutat Res; 1982 Oct; 105(4):211-21. PubMed ID: 6752704
[TBL] [Abstract][Full Text] [Related]
20. Optimization of a pre-metabolization procedure using rat liver S9 and cell-extracted S9 in the Ames fluctuation test.
Shao Y; Schiwy A; Glauch L; Henneberger L; König M; Mühlenbrink M; Xiao H; Thalmann B; Schlichting R; Hollert H; Escher BI
Sci Total Environ; 2020 Dec; 749():141468. PubMed ID: 32827816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
